Breaking News, Trials & Filings

Trials & Filings in Brief: Jan. 10, 2014

Immunomedics, MannKind, Neurocrine, Stem Cells, Synta Pharma,

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I Stem Cells gets first North American spinal subject . . . read more   Phase II Neurocrine posts more TD results . . . read more   Phase III Immunomedics begins dosing with pancreatic cancer ADC . . . read more   Synta to begin three trials in AML, MDS . . . read more   Filings MannKind’s inhalable insuling gets committee date . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters